Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient Endothelial Colony-Forming Cells to Model Coronary Artery Disease Susceptibility and Unravel the Role of Dysregulated Mitochondrial Redox Signalling.
Besnier M, Finemore M, Yu C, Kott KA, Vernon ST, Seebacher NA, Genetzakis E, Furman A, Tang O, Davis RL, Hansen T, Psaltis PJ, Bubb KJ, Wise SG, Grieve SM, Di Bartolo BA, Figtree GA. Besnier M, et al. Among authors: finemore m. Antioxidants (Basel). 2021 Sep 29;10(10):1547. doi: 10.3390/antiox10101547. Antioxidants (Basel). 2021. PMID: 34679682 Free PMC article.
Immunoglobulin E Sensitization to Mammalian Oligosaccharide Galactose-α-1,3 (α-Gal) Is Associated With Noncalcified Plaque, Obstructive Coronary Artery Disease, and ST-Segment-Elevated Myocardial Infarction.
Vernon ST, Kott KA, Hansen T, Finemore M, Baumgart KW, Bhindi R, Yang J, Hansen PS, Nicholls SJ, Celermajer DS, Ward MR, van Nunen SA, Grieve SM, Figtree GA. Vernon ST, et al. Among authors: finemore m. Arterioscler Thromb Vasc Biol. 2022 Mar;42(3):352-361. doi: 10.1161/ATVBAHA.121.316878. Epub 2022 Jan 20. Arterioscler Thromb Vasc Biol. 2022. PMID: 35045730
The novel P2X7 receptor antagonist PKT100 improves cardiac function and survival in pulmonary hypertension by direct targeting of the right ventricle.
Hansen T, Karimi Galougahi K, Besnier M, Genetzakis E, Tsang M, Finemore M, O'Brien-Brown J, Di Bartolo BA, Kassiou M, Bubb KJ, Figtree GA. Hansen T, et al. Among authors: finemore m. Am J Physiol Heart Circ Physiol. 2020 Jul 1;319(1):H183-H191. doi: 10.1152/ajpheart.00580.2019. Epub 2020 May 29. Am J Physiol Heart Circ Physiol. 2020. PMID: 32469637 Free article.
Protocol for the Stimulating β3-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease.
Bubb KJ, Harmer JA, Finemore M, Aitken SJ, Ali ZS, Billot L, Chow C, Golledge J, Mister R, Gray MP, Grieve SM, Hamburg N, Keech AC, Patel S, Puttaswamy V, Figtree GA. Bubb KJ, et al. Among authors: finemore m. BMJ Open. 2021 Sep 28;11(9):e049858. doi: 10.1136/bmjopen-2021-049858. BMJ Open. 2021. PMID: 34588252 Free PMC article.